EIC Summit 25 Networking Platform

2–3 Apr 2025 | Brussels, Belgium

Niek Savelkoul

CEO

Scope Biosciences B.V.

Wageningen, Netherlands

8 profile visitsEIC Beneficiary

Founder and CEO of Scope Biosciences B.V. - Rapid accurate onsite diagnostics with CRISPR-Cas

My organisation

Scope Biosciences B.V.

Scope Biosciences B.V.

Start-ups and SMEs

Wageningen, Netherlands

Scope Biosciences B.V. is a Dutch biotech company pioneering next-generation molecular diagnostics through its patented scopeDx® platform, based on a unique type III CRISPR-Cas system. A spin-off from Wageningen University, Scope Biosciences aims to democratize diagnostics by combining the speed and ease-of-use of immunoassays with the accuracy of PCR, delivering results within 30 minutes at the point-of-care. Under the EU-funded EIC Transition project (2024–2026), the company is advancing scopeDx® from proof-of-concept to a complete sample-to-answer solution for clinical applications, emphasizing modularity, specificity (SNP-level), and on-site usability
Read more

About me

Social media

Marketplace (2)